Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fluorouracil 4% cream
0801030H0AABLBL
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | 419 |
|
Tolak 40mg/g cream
0801030H0BGAABL
|
Tolak | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | 316 |
|
Carac 0.5% cream
0801030H0BFAAAV
|
Carac | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluoroplex 1% cream
0801030H0BDAAAX
|
Fluoroplex | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 0.5% cream
0801030H0AAAVAV
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 1.1g/44ml inj pre-filled syringes
0801030H0AABDBD
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 1.2g/48ml inj pre-filled syringes
0801030H0AABEBE
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 1% cream
0801030H0AAAXAX
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 1g/20ml solution for injection vials
0801030H0AAAWAW
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 1g/40ml inj pre-filled syringes
0801030H0AABCBC
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 2.5g/100ml solution for infusion vials
0801030H0AAAEAE
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 2.5g/50ml solution for infusion vials
0801030H0AAATAT
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 200mg/8ml inj pre-filled syringes
0801030H0AABFBF
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 250mg capsules
0801030H0AAAAAA
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 250mg/10ml solution for injection vials
0801030H0AAAHAH
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 250mg/5ml solution for injection vials
0801030H0AABBBB
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 500mg/10ml solution for injection vials
0801030H0AAARAR
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 500mg/20ml inj pre-filled syringes
0801030H0AABGBG
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 500mg/20ml solution for injection vials
0801030H0AAADAD
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 5g/100ml solution for infusion vials
0801030H0AAAUAU
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 600mg/24ml inj pre-filled syringes
0801030H0AABHBH
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 800mg/32ml inj pre-filled syringes
0801030H0AABIBI
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 900mg/36ml inj pre-filled syringes
0801030H0AABJBJ
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 950mg/38ml inj pre-filled syringes
0801030H0AABKBK
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.